This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA

Dr Erica Dawson
Chief Research and Development Officer at InDevR, Inc.
Speaker

Profile

Dr. Erica Dawson is Chief R&D Officer at InDevR, a Boulder, CO-based life science tools company founded in 2003 where she leads the R&D, Engineering, and Field Application Science teams. In this role that straddles product development and commercial activities, she guides the development and expansion of InDevR’s VaxArray technology portfolio and related IP as well as oversees the team of scientists providing customer support. With InDevR since 2006, Dr. Dawson has acted as program manager or PI on most of InDevR’s historical ~$45M in non-dilutive grants and contracts, including current or past funding from NIH/NIAID, the Bill & Melinda Gates Foundation, and NIIMBL. In addition, she led a $15M BARDA contract for the development of an influenza molecular diagnostic with clinical and pandemic preparedness applications which resulted in successful 510(k) clearance in April 2019. Dr. Dawson earned her B.S. in Chemistry from Hartwick College (summa cum laude), her Ph.D. in Analytical Chemistry from The University of North Carolina at Chapel Hill, and completed postdoctoral training in microarray-based molecular diagnostics at the University of Colorado at Boulder.

Agenda Sessions

  • VaxArray Multiplexed Analytics for mRNA-based Vaccines and Therapeutics

    12:30pm